Abstract
Platelet activating factor (PAF), a naturally occurring phospholipid with many potent physiological and pharmacological activities, is implicated as a mediator of many diseases. An immunoassay for PAF would greatly improve quantitation, and hence PAF-specific antibodies were required. Chemically-reactive analogs of PAF, containing an aldehyde group at the end of the 1-O-alkyl chain (hexyl or dodecyl), were synthesized from readily available materials. During the multi-step synthetic procedure, the aldehyde group was protected as an acetal, which was converted by mild acidic hydrolysis to the aldehyde immediately prior to protein coupling. These analogs were coupled to methylated bovine serum albumin and the resultant conjugates were injected into rabbits. Antibodies to PAF were detected using a solid phase radioimmunoassay based on Protein A-Sepharose. The dodecyl PAF conjugate proved to be the more immunogenic conjugate with more than half of the rabbits producing significant levels of antibodies (at least a 10-fold increase in radioactive uptake over pre-immune levels). Results from solid phase immunoassays employing nitrocellulose discs impregnated with PAF, lysoPAF, lecithin, lysolecithin and 2-O-methyl-lysoPAF indicated that the antibodies recognized only PAF. PAF-specific antibodies were isolated by affinity chromatography using a column of PAF-poly(lysine) conjugated to carboxy-activated polyacrylamide. The antibodies may be employed in a sensitive and specific immunoassay for PAF and for many other studies involving PAF.
Similar content being viewed by others
Abbreviations
- Ac:
-
acetyl
- BSA:
-
bovine serum albumin
- C n PAF:
-
PAF where the 1-O-alkyl chain isn carbons long
- CS:
-
human cord serum
- DMOC6PAF:
-
1-O-(6′,6′-dimethoxyhexyl)-2-acetyl-sn-glycero-3-phosphocholine
- DMOC12PAF:
-
1-O-(12′,12′-dimethoxydodecyl)-2-acetyl-sn-glycero-3-phosphocholine
- Ig:
-
immunoglobulin
- [125I]PAF:
-
1-O-[125I]alkyl-2-acetyl-sn-glycero-3-phosphocholine
- lysoPAF:
-
1-O-alkyl-sn-glycero-3-phosphocholine
- MBSA:
-
methylated bovine serum albumin
- 2-O-methyl-lysoPAF:
-
1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine
- NC:
-
nitrocellulose
- PA:
-
polyacrylamide
- PAF:
-
platelet activating factor, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine
- PAF-PL-PA:
-
PAF-poly(lysine)-polyacrylamide
- PBS:
-
phosphate (50 mM) buffered saline pH 7.2
- PL-PA:
-
poly(lysine)-PA
References
Hanahan, D.J. (1986)Annu. Rev. Biochem. 55, 483–509.
Braquet, P., Touqui, L., Shen, T.Y., and Vargaftig, B.B. (1987)Pharmacol. Rev. 39, 97–145.
Benveniste, J., Henson, P.M., and Cochrane, C.G. (1972)J. Exp. Med. 136, 1356–1377.
Hanahan, D.J., Demopoulos, C.A., Liehr, J., and Pinckard, R.N. (1980)J. Biol. Chem. 255, 5514–5516.
Snyder, F. (1985)Med. Res. Rev. 5, 107–140.
Lee, T.-C. (1987) inPlatelet-Activating Factor and Related Lipid Mediators (Snyder, F., ed.), pp. 115–133, Plenum Press, New York.
Barnes, P.J. (1988)J. Allergy Clin. Immunol. 81, 152–160.
Page, C.P. (1988)J. Allergy Clin. Immunol. 81, 144–151.
Barnes, P.J., Chung, K.F., and Page, C.P. (1988)J. Allergy Clin. Immunol. 81, 919–934.
Terashita, Z.-I., Imura, Y., Shino, A., And Nishikawa, K. (1987)J. Pharmacol. Exp. Ther. 243, 378–383.
Etienne, A., Hecquet, F., Soulard, C., Spinnewyn, B., Clostre, F., and Braquet, P. (1985)Agents Actions 17, 368–370.
Schlondorff, D., and Neuwirth, R. (1986)Am. J. Physiol. 251, F1-F11.
Hanahan, D.J., and Weintraub, S.T. (1985)Methods Biochem. Anal. 31, 195–219.
Wykle, R.L., O'Flaherty, J.T., and Thomas, M.J. (1988)Methods Enzymol. 163, 44–54.
Hirth, G., and Barner, R. (1982)Helv. Chim. Acta 65, 1059–1084.
Rosenthal, A.F. (1975)Methods Enzymol. 35, 429–529.
Schmidt, U., and Grafen, P. (1962)Liebigs Annal. Chem. 656, 97–102.
Smal, M.A., Baldo, B.A., and Redmond, J.W. (1989)Mol. Immunol. 26, 711–719.
Dickinson, R.G., and Jacobsen, N.W. (1970)Chem. Commun. 1719–1720.
Ames, B.N., (1966)Methods Enzymol. 8, 115–118.
Coeffier, E., Ninio, E., Le Couedic, J.P., and Chignard, M. (1986)Br. J. Haematol., 62, 641–652.
Huo, Y., Ekholm, J., and Hanahan, D.J. (1988)Arch. Biochem. Biophys. 260, 841–846.
Inman, J.K., and Dintzis, H.M. (1969)Biochemistry 8, 4074–4082.
Goding, J.W. (1976)J. Immunol. Methods 13, 213–226.
Bradford, M.M. (1976)Anal. Biochem. 72, 248–254.
Stafforini, D.M., Prescott, S.M., and McIntyre, T.M. (1987)J. Biol. Chem. 262, 4223–4230.
Nishihira, J., Ishibashi, T., and Imai, Y. (1984)J. Biochem. (Tokyo) 95, 1247–1251.
Karasawa, K., Fujita, K., Satoh, N., Hongo, T., Setaka, M., Ohno, M., and Nojima, S. (1987)J. Biochem. (Tokyo) 102, 451–453.
Cooney, S.J., Smal, M.A., Harle, D.G., and Baldo, B.A. (1990)Mol. Immunol. 27, 405–412.
Valone, F.H. (1984)Immunology 52, 169–174.
Baldo, B.A., Smal, M.A., and McCaskill, A.C. (1991)Lipids, 26, 1136–1139.
Baldo, B.A., Smal, M.A. and Redmond, J.W. (1988) inThe Role of Platelet-Activating Factor in Immune Disorders (Braquet, P., ed.) pp. 204–210, Karger, Basel.
Author information
Authors and Affiliations
About this article
Cite this article
Smal, M.A., Baldo, B.A. & Redmond, J.W. Synthesis of a PAF immunogen and production of PAF-specific antibodies. Lipids 26, 1130–1135 (1991). https://doi.org/10.1007/BF02536516
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536516